首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 核酸藥物

市場調查報告書

商品編碼

2052311

肽類治療市場：依產品類型、應用、給藥途徑及地區分類

Peptide Therapeutics Market, By Product Type, By Application, By Route of Administration, and By Region

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，胜肽類藥物市場規模將達到538.693億美元，到2033年將達到853.768億美元。預計從2026年到2033年，該市場將以6.8%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	538.693億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.80%	2033年市場規模預測：	853.768億美元

由於採用新型生產、修飾和分析技術的進步，胜肽類藥物的研發取得了顯著進展。肽類藥物的生產和修飾可透過化學和生物學方法實現，新的設計和遞送策略也正被應用於克服肽類藥物特有的缺陷，從而推動該領域的持續發展。目前，種類繁多的天然和修飾肽類藥物已被用於研究，涵蓋心臟病學、免疫學、皮膚病學和腫瘤學等多個治療領域。進入21世紀，肽類藥物的研發進入了一個新時代。此後，結構生物學、重組生技藥品以及新型合成和分析技術的進步大大加速了這一進程。如今，已建立了一套完善的胜肽類藥物研發體系，涵蓋胜肽類藥物發現、藥物設計、胜肽合成、結構修飾和活性評估等各環節。

治療性胜肽是一類獨特的藥物，其分子量通常為 500 至 5000 Da，由具有良好有序序列的胺基酸組成。

市場動態

市場參與者正在開發新型創新胜肽療法，透過增強生物相容性和顯著的治療效果，為目標患者提供量身定做的解決方案。預計癌症、心血管疾病和糖尿病的日益普及將推動胜肽療法市場在預測期內的成長。

市場正加速採用內部成長策略，例如透過合作來拓展產品系列，主要企業紛紛效仿，預計將推動預測期內的市場成長。例如，2023年1月，全球最大的製藥公司之一禮來公司和全球醫療保健公司默克宣佈在胜肽標靶藥物遞送領域展開合作，並將共同收購生物製藥公司PeptiDream。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數創建了全球肽類藥物市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
本報告中的見解將使企業負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球胜肽類藥物市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析全球胜肽類藥物市場中使用的各種策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Teva Pharmaceutical Industries Ltd.
Novo Nordisk A/S
OPKO Health, Inc.
Lilly
Hanmi Pharm.Co.
Sanofi
Circle Pharma
Pfizer Inc.
Novartis AG
PeptiDream Inc.
Amgen Inc.
AstraZeneca
Bachem Holding AG
CordenPharma International
Ipsen Pharma
Merck KGaA
PolyPeptide Group
Bayer AG

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI1837

Peptide Therapeutics Market is estimated to be valued at USD 53,869.3 Mn in 2026 and is expected to reach USD 85,376.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 53,869.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.80%	2033 Value Projection:	USD 85,376.8 Mn

Peptide drug development has grown immensely due to new manufacturing, modification, and analytical techniques. Peptides are generated and modified using both chemical and biological methods, along with new design and delivery strategies that overcomes the inherent drawbacks of peptide and enables continued progress in this field. A wide variety of natural and modified peptides have been obtained and studied covering multiple therapeutic area such as cardio metabolic, immunology and dermatology, oncology, etc. Peptide drug development entered a new era with the advent of the 21st century, since then advances in structural biology, recombinant biologics, and new synthetic and analytic technologies have significantly accelerated the process. A sophisticated system of peptide drug development has been established, including peptide drug discovery, drug design, peptide synthesis, structural modification, and activity evaluation.

Therapeutic peptides are a unique class of pharmaceuticals composed of an ordered series of amino acids, typically with molecular weights between 500 and 5000 Da.

Market Dynamics

Market players are developing novel and innovative peptide therapeutics to provide tailored solutions for target patients, by enhancing biocompatibility and potent therapeutic efficacy. Increasing prevalence of cancer, cardiovascular diseases, and diabetes mellitus is projected to drive growth of the peptide therapeutics market over the forecast period.

Increasing adoption of organic growth strategies such as collaborations by key players in the market in order to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2023, Lilly, one of the world's largest pharmaceutical companies, and Merck, a global healthcare company, announced their partnership for peptide-targeted drug delivery, collaborating to acquire PeptiDream which is a biopharmaceutical company.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global peptide therapeutics market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study Teva Pharmaceutical Industries Ltd, Novo Nordisk A/S, OPKO Health, Inc., Lilly, Hanmi Pharm.Co., Sanofi, Circle Pharma, Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global peptide therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide therapeutics market

Peptide Therapeutics Market Segmentation

Product Type Insights (Revenue, USD Mn, 2021 - 2033)
Branded Peptide
Generic Peptide
Application Insights (Revenue, USD Mn, 2021 - 2033)
Cancer
Cardiovascular diseases
Metabolic diseases
Respiratory diseases
Infectious diseases
Others
Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
Oral Administration
Parenteral Administration
Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Teva Pharmaceutical Industries Ltd
Novo Nordisk A/S
OPKO Health Inc.
Lilly
Hanmi Pharm.Co.
Sanofi
Circle Pharma
Pfizer Inc.
Novartis AG
PeptiDream Inc.
Amgen Inc.
AstraZeneca
Bachem Holding AG
CordenPharma International
Ipsen Pharma
Merck KGaA
PolyPeptide Group
Bayer AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Route of Administration
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
PORTER's Analysis
Pricing Analysis (2022)

4. Global Peptide Therapeutics Market, By Product Type, 2021-2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Branded Peptide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Generic Peptide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

5. Global Peptide Therapeutics Market, By Application, 2021-2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Cardiovascular Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Metabolic Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

6. Global Peptide Therapeutics Market, By Route of Administration, 2021-2033, (US$ Million)

Oral Administration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Parenteral Administration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

7. Global Peptide Therapeutics Market, By Region, 2021-2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021-2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
OPKO Health, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lilly
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hanmi Pharm.Co.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Circle Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PeptiDream Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bachem Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CordenPharma International
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ipsen Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PolyPeptide Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies